Publications:

Seeking a better understanding of the non-receptor tyrosine kinase, SRMS.

Heliyon

Goel, Raghuveera Kumar RK; Kim, Nayoung N; Lukong, Kiven Erique KE

Publication Date: 2023-06

Variant appearance in text: IGF1R: Y527F

PubMed Link: 37251450

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer.

Oncotarget

McGivern, Niamh N; El-Helali, Aya A; Mullan, Paul P; McNeish, Iain A IA; Paul Harkin, D D; Kennedy, Richard D RD; McCabe, Nuala N

Publication Date: 2018-01-12

Variant appearance in text: IGF1R: Y527F

PubMed Link: 29435137

Variant Present in the following documents:

• Main text
• oncotarget-09-4722.pdf

View BVdb publication page

Androgen and Src signaling regulate centrosome activity.

Journal Of Cell Science

Colello, Diane D; Reverte, Carlos G CG; Ward, Rachel R; Jones, Christopher W CW; Magidson, Valentin V; Khodjakov, Alexey A; LaFlamme, Susan E SE

Publication Date: 2010-06-15

Variant appearance in text: IGF1R: Y527F

PubMed Link: 20501699

Variant Present in the following documents:

• Main text

View BVdb publication page

SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.

Molecular And Cellular Biology

Blake, R A RA; Broome, M A MA; Liu, X X; Wu, J J; Gishizky, M M; Sun, L L; Courtneidge, S A SA

Publication Date: 2000-12

Variant appearance in text: IGF1R: Y527F

PubMed Link: 11074000

Variant Present in the following documents:

• Main text

View BVdb publication page